Cardiff Oncology, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Cardiff Oncology, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Cardiff Oncology, Inc. Return On Equity for the quarter ending June 30, 2024 was -62.7 %, a 59.1% decline year-over-year.
  • Cardiff Oncology, Inc. annual Return On Equity for 2023 was -50.1 %, a 52.2% decline from 2022.
  • Cardiff Oncology, Inc. annual Return On Equity for 2022 was -32.9 %, a 56.4% decline from 2021.
  • Cardiff Oncology, Inc. annual Return On Equity for 2021 was -21.1 %, a 47.6% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -50.1 -17.2 -52.2% Jan 1, 2023 Dec 31, 2023
2022 -32.9 -11.9 -56.4% Jan 1, 2022 Dec 31, 2022
2021 -21.1 +19.1 +47.6% Jan 1, 2021 Dec 31, 2021
2020 -40.2 +162 +80.1% Jan 1, 2020 Dec 31, 2020
2019 -202 -59.6 -41.8% Jan 1, 2019 Dec 31, 2019
2018 -142 +262 +64.8% Jan 1, 2018 Dec 31, 2018
2017 -404 -274 -210% Jan 1, 2017 Dec 31, 2017
2016 -130 -54.7 -72.3% Jan 1, 2016 Dec 31, 2016
2015 -75.7 +27.1 +26.3% Jan 1, 2015 Dec 31, 2015
2014 -103 +13.7 +11.7% Jan 1, 2014 Dec 31, 2014
2013 -116 +441 +79.1% Jan 1, 2013 Dec 31, 2013
2012 -557 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.